Navigation Links
NIH announces new initiative in epigenomics
Date:1/24/2008

The National Institutes of Health (NIH) will invest more than $190 million over the next five years to accelerate an emerging field of biomedical research known as epigenomics.

"Disease is about more than genetics. It's about how genes are regulated -- how and when they work in both health and disease," said NIH Director Elias A. Zerhouni, M.D. "Epigenomics will build upon our new knowledge of the human genome and help us better understand the role of the environment in regulating genes that protect our health or make us more susceptible to disease."

The NIH is making this a priority in its research portfolio, taking it on as an NIH Roadmap initiative. Grant applications are now being accepted for research on epigenome mapping centers, epigenomics data analysis and coordination, technology development in epigenetics, and discovery of novel epigenetic marks in mammalian cells.

Epigenetics focuses on processes that regulate how and when certain genes are turned on and turned off, while epigenomics pertains to analysis of epigenetic changes across many genes in a cell or entire organism.

Epigenetic processes control normal growth and development. Diet and exposure to environmental chemicals throughout all stages of human development among other factors can cause epigenetic changes that may turn on or turn off certain genes. Changes in genes that would normally protect against a disease, as a result, could make people more susceptible to developing that disease later in life. Researchers also believe some epigenetic changes can be passed on from generation to generation.

The Epigenomics Program is a trans-NIH effort led by several NIH institutes including the National Institute of Environmental Health Sciences, the National Institute on Drug Abuse (NIDA), the National Institute on Deafness and Other Communication Disorders, the National Institute of Diabetes and Digestive and Kidney Diseases, the National Institute of N
'/>"/>

Contact: Karen Silver
silverk@mail.nih.gov
301-435-2435
NIH/Office of the Director
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. BD Announces Results For First Fiscal Quarter
2. Cogdell Spencer Inc. Announces Merger with Marshall Erdman and Associates
3. KV Pharmaceutical Company Announces Acquisition of Rights to Gestiva(TM)
4. Euro RSCG Life LM&P Announces Growth of Leadership Team
5. DSS Announces Market Research Program for the Design of 2009 MA and PDP Products and Marketing Programs
6. International consortium announces the 1000 Genomes Project
7. TeamHealth Announces Eight New Clinical Outsourcing Contracts
8. Moog Inc. Announces First Quarter 2008 Earnings Webcast on January 25, 2008
9. Pharmacyclics Announces Conference Call to Discuss Second Quarter 2008 Financial Results
10. Bradley Pharmaceuticals Announces Filing of Definitive Proxy Statement for Special Meeting of Stockholders to Approve Merger With Nycomed
11. Immunosyn Announces the Successful Completion of First Phase Proof of Concept Trial in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... June 02, 2015 With a dedicated focus ... & Health Care has hired Leslie Young as director ... human resource initiatives to better understand and respond to the ... Tutera’s 47 communities in 13 states across the country. , ... of personalized support to our residents, we are making it ...
(Date:6/2/2015)... June 02, 2015 DiaTech Oncology, ... response profiling test to help oncologists provide personalized ... of American Pathologists (CAP) for its laboratories in ... certification is equivalent to the ‘Good Housekeeping’ seal ... chief executive officer for DiaTech. “It’s a rigorous ...
(Date:6/2/2015)... Though almost the entire Park family was born with HHT, ... lives. Organizing and hosting the June 14 event is just ... fullest and spreading awareness of HHT. , “I've been scanned ... my life in a bubble because something bad might happen,” ... look back on your life with regret because you let ...
(Date:6/2/2015)... 02, 2015 For those that have ... exposed to harmful germs, chemicals and bodily fluids from ... to an inventor from Queens Village, N.Y., their worries ... an efficient, fun, hygienic way to store and dispense ... to bugs, chemicals and germs. Furthermore, it insures that ...
(Date:6/2/2015)... June 02, 2015 The health care ... a pioneering provider of value-based care will now offer ... Orange and Sullivan Counties. The newly launched Crystal Run ... its commercial Small Group Preferred Provider Organization (PPO) and ... Run Healthcare’s Managing Partner and CEO, Hal Teitelbaum, ...
Breaking Medicine News(10 mins):Health News:Tutera Senior Living & Health Care Hires HR Pro Leslie Young to Lead New Initiatives to Become Employer of Choice 2Health News:Tutera Senior Living & Health Care Hires HR Pro Leslie Young to Lead New Initiatives to Become Employer of Choice 3Health News:Tutera Senior Living & Health Care Hires HR Pro Leslie Young to Lead New Initiatives to Become Employer of Choice 4Health News:DiaTech Oncology Gains College of American Pathologists Accreditation for U.S. CorrectChemo Laboratory 2Health News:Family brings awareness to genetic disease at first Memphis walk 2Health News:Dental Storage and Dispensing Unit Invented by InventHelp Client (LGI-1890) 2Health News:Leading Health Care Innovator Poised to Deliver New Health Coverage Options To The Hudson Valley Region 2Health News:Leading Health Care Innovator Poised to Deliver New Health Coverage Options To The Hudson Valley Region 3
... , , DURHAM, N.C., Sept. 22 ... chairman and CEO, Chris Stern, will present at an investor conferences in ... will be at the Zurich Airport Radisson Hotel and is scheduled for ... be open to interested investors. , , ...
... , , , FALLS ... (NYSE: CSC ) today announced the successful implementation ... electronic health record (EHR) system, PRISM (Patient Record and Information ... is now operational in the hospital,s inpatient areas as well ...
... , , Changes Reflect Provisions ... Sept. 22 URAC , a leading health care ... now open for proposed changes to its Independent Review Organization (IRO) Standards, ... health plans are encouraged to provide their comments on t he ...
... , , MOUNTAIN VIEW, Calif., ... for clot removal in ischemic stroke patients, today announced the launch ... are a first-in-class family of devices used to provide distal access ... neurovascular procedures. , , The original DAC ...
... , JACKSONVILLE, Fla., Sept. 22 VISTAKON(R), Division of Johnson ... is offering movie fans a chance to win a hometown screening of ... friends. The grand prize also includes autographed skates, poster and book, ... , Fans can enter the ACUVUE(R) WHIP IT Sweeps ...
... , , MOUNTAIN VIEW, Calif., ... today announced publication of results from an in vitro ... development exploring the potential mechanism by which the pharmacokinetics (PK) and ... with intravenous dihydroergotamine (DHE). Results will be published in a manuscript ...
Cached Medicine News:Health News:CSC Helps Fletcher Allen Health Care Implement Phase One of Electronic Health Records System in 15 Months 2Health News:CSC Helps Fletcher Allen Health Care Implement Phase One of Electronic Health Records System in 15 Months 3Health News:URAC Open Public Comment Period for New Independent Review Organization Standards 2Health News:URAC Open Public Comment Period for New Independent Review Organization Standards 3Health News:Concentric Medical Launches Full Family of DAC(TM) Neurovascular Catheters 2Health News:ACUVUE(R) Brand Contact Lenses Gives Movie Fans a Chance to Win a Hometown Screening of WHIP IT 2Health News:ACUVUE(R) Brand Contact Lenses Gives Movie Fans a Chance to Win a Hometown Screening of WHIP IT 3Health News:'Headache' Publication Describes Potential Mechanistic Rationale for LEVADEX(TM) Favorable Adverse Event Profile 2Health News:'Headache' Publication Describes Potential Mechanistic Rationale for LEVADEX(TM) Favorable Adverse Event Profile 3Health News:'Headache' Publication Describes Potential Mechanistic Rationale for LEVADEX(TM) Favorable Adverse Event Profile 4
(Date:6/2/2015)... ANGELES , June 2, 2015  CytRx Corporation ... company specializing in oncology, today announced that it has ... pending in the Delaware Court ... the Company,s current and former directors and officers, and ... The lawsuit, captioned In re CytRx Corp. Stockholder ...
(Date:6/2/2015)... DUBLIN , June 02, 2015 ... the addition of the "Electrophysiology Market by ... (Cryoablation, RF, Microwave), Lab Devices (Mapping, Recording, Generator, ... Global Forecasts to 2019" report to their ... is estimated to grow at a significant CAGR ...
(Date:6/2/2015)... , Minn. and WELLESLEY, Mass., June 2, 2015 /PRNewswire/ ... principal owner, Ampersand Capital Partners (Ampersand), announced the ... operation of Array BioPharma Inc. (Array).  Accuratus was ... Eagan, MN acquired Microtest ... GLP analytical and microbial testing services to the ...
Breaking Medicine Technology:CytRx Announces Settlement of Stockholder Derivative Lawsuit in Delaware 2CytRx Announces Settlement of Stockholder Derivative Lawsuit in Delaware 3CytRx Announces Settlement of Stockholder Derivative Lawsuit in Delaware 4Global Electrophysiology Market Report 2015-2019 - Product, Ablation Catheter, Lab Devices & Indication Analysis 2Global Electrophysiology Market Report 2015-2019 - Product, Ablation Catheter, Lab Devices & Indication Analysis 3Accuratus Lab Services Expands Capabilities with Acquisition of CMC Operation of Array BioPharma 2Accuratus Lab Services Expands Capabilities with Acquisition of CMC Operation of Array BioPharma 3
... July 7, 2010 Elsevier is,pleased to announce the appointment of prominent new ... , , ... , , , ... is clinical research lead at the Department of,Endocrinology, Diabetes and Metabolism at Beth Israel ...
... , July 6 US WorldMeds is ... for injection), the first patented scientific advancement in the ... dantrolene sodium for injection has been dramatically reduced to ...  Revonto™ retains the cost-savings of the original dantrolene sodium ...
Cached Medicine Technology:Elsevier Appoints Top Diabetes and Endocrinology Researchers as Editors 2Elsevier Appoints Top Diabetes and Endocrinology Researchers as Editors 3Elsevier Appoints Top Diabetes and Endocrinology Researchers as Editors 4Elsevier Appoints Top Diabetes and Endocrinology Researchers as Editors 5Elsevier Appoints Top Diabetes and Endocrinology Researchers as Editors 6US WorldMeds Announces the Launch of Revonto™ (dantrolene sodium for injection) 2
... a monoclonal antibody based colorimetric test ... Neisseria gonorrhoeae. The test requires less ... no heating or pretreatment. The test ... fresh cultures. GonoGen&trade II eliminates agglutination, ...
Culture Confirmation Tests...
... GC is a novel device for ... Neisseria gonorrhoeae and Neisseria meningitidis. ... life and is easily transportable as ... inoculate, incubate and examine the growth ...
... (Nidek Advanced Vision Information System) is an ... software on a platform designed to communicate ... The network can be expanded in various ... to Nidek products but also to fundus ...
Medicine Products: